284 related articles for article (PubMed ID: 18519799)
41. Fibre-type specific modification of the activity and regulation of skeletal muscle pyruvate dehydrogenase kinase (PDK) by prolonged starvation and refeeding is associated with targeted regulation of PDK isoenzyme 4 expression.
Sugden MC; Kraus A; Harris RA; Holness MJ
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):651-7. PubMed ID: 10698691
[TBL] [Abstract][Full Text] [Related]
42. Regulation of Pyruvate Dehydrogenase Kinase 4 in the Heart through Degradation by the Lon Protease in Response to Mitochondrial Substrate Availability.
Crewe C; Schafer C; Lee I; Kinter M; Szweda LI
J Biol Chem; 2017 Jan; 292(1):305-312. PubMed ID: 27856638
[TBL] [Abstract][Full Text] [Related]
43. Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids.
Bajotto G; Murakami T; Nagasaki M; Qin B; Matsuo Y; Maeda K; Ohashi M; Oshida Y; Sato Y; Shimomura Y
Metabolism; 2006 Mar; 55(3):317-23. PubMed ID: 16483874
[TBL] [Abstract][Full Text] [Related]
44. Regulation of adipose triglyceride lipase by rosiglitazone.
Liu LF; Purushotham A; Wendel AA; Koba K; DeIuliis J; Lee K; Belury MA
Diabetes Obes Metab; 2009 Feb; 11(2):131-42. PubMed ID: 18643838
[TBL] [Abstract][Full Text] [Related]
45. Selective modification of the pyruvate dehydrogenase kinase isoform profile in skeletal muscle in hyperthyroidism: implications for the regulatory impact of glucose on fatty acid oxidation.
Sugden MC; Lall HS; Harris RA; Holness MJ
J Endocrinol; 2000 Nov; 167(2):339-45. PubMed ID: 11054649
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional regulation of pyruvate dehydrogenase kinase.
Jeong JY; Jeoung NH; Park KG; Lee IK
Diabetes Metab J; 2012 Oct; 36(5):328-35. PubMed ID: 23130316
[TBL] [Abstract][Full Text] [Related]
47. Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis.
Chen JL; Peacock E; Samady W; Turner SM; Neese RA; Hellerstein MK; Murphy EJ
J Biol Chem; 2005 Jul; 280(27):25396-402. PubMed ID: 15888453
[TBL] [Abstract][Full Text] [Related]
48. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
[TBL] [Abstract][Full Text] [Related]
49. Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation.
Pettersen IKN; Tusubira D; Ashrafi H; Dyrstad SE; Hansen L; Liu XZ; Nilsson LIH; Løvsletten NG; Berge K; Wergedahl H; Bjørndal B; Fluge Ø; Bruland O; Rustan AC; Halberg N; Røsland GV; Berge RK; Tronstad KJ
Mitochondrion; 2019 Nov; 49():97-110. PubMed ID: 31351920
[TBL] [Abstract][Full Text] [Related]
50. Site-specific modulation of white adipose tissue lipid metabolism by oleoyl-estrone and/or rosiglitazone in overweight rats.
Ferrer-Lorente R; Cabot C; Fernández-López JA; Alemany M
Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):339-48. PubMed ID: 20195573
[TBL] [Abstract][Full Text] [Related]
51. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.
Kim HJ; Jung TW; Kang ES; Kim DJ; Ahn CW; Lee KW; Lee HC; Cha BS
Metabolism; 2007 May; 56(5):676-85. PubMed ID: 17445544
[TBL] [Abstract][Full Text] [Related]
52. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators.
Martin G; Schoonjans K; Lefebvre AM; Staels B; Auwerx J
J Biol Chem; 1997 Nov; 272(45):28210-7. PubMed ID: 9353271
[TBL] [Abstract][Full Text] [Related]
53. Rosiglitazone up-regulates lipoprotein lipase, hormone-sensitive lipase and uncoupling protein-1, and down-regulates insulin-induced fatty acid synthase gene expression in brown adipocytes of Wistar rats.
Teruel T; Hernandez R; Rial E; Martin-Hidalgo A; Lorenzo M
Diabetologia; 2005 Jun; 48(6):1180-8. PubMed ID: 15887043
[TBL] [Abstract][Full Text] [Related]
54. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
Gopal K; Saleme B; Al Batran R; Aburasayn H; Eshreif A; Ho KL; Ma WK; Almutairi M; Eaton F; Gandhi M; Park EA; Sutendra G; Ussher JR
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H479-H490. PubMed ID: 28687587
[TBL] [Abstract][Full Text] [Related]
55. Muscle fiber type comparison of PDH kinase activity and isoform expression in fed and fasted rats.
Peters SJ; Harris RA; Heigenhauser GJ; Spriet LL
Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R661-8. PubMed ID: 11171643
[TBL] [Abstract][Full Text] [Related]
56. Fatty acids and fibrates are potent inducers of transcription of the phosphenolpyruvate carboxykinase gene in adipocytes.
Antras-Ferry J; Robin P; Robin D; Forest C
Eur J Biochem; 1995 Dec; 234(2):390-6. PubMed ID: 8536680
[TBL] [Abstract][Full Text] [Related]
57. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro.
McTernan PG; Harte AL; Anderson LA; Green A; Smith SA; Holder JC; Barnett AH; Eggo MC; Kumar S
Diabetes; 2002 May; 51(5):1493-8. PubMed ID: 11978647
[TBL] [Abstract][Full Text] [Related]
58. Evidence for an important role of CIDEA in human cancer cachexia.
Laurencikiene J; Stenson BM; Arvidsson Nordström E; Agustsson T; Langin D; Isaksson B; Permert J; Rydén M; Arner P
Cancer Res; 2008 Nov; 68(22):9247-54. PubMed ID: 19010897
[TBL] [Abstract][Full Text] [Related]
59. Effect of glucocorticoids on glyceroneogenesis in adipose tissue: A systematic review.
Marcondes-de-Mello ML; Serafim-Costa MC; Alves-E-Silva MM; Oliveira NR; Bertolucci-Caldo NV; Ferraz RK; Chaves VE
Biochimie; 2020 Jan; 168():210-219. PubMed ID: 31759936
[TBL] [Abstract][Full Text] [Related]
60. Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin.
Connaughton S; Chowdhury F; Attia RR; Song S; Zhang Y; Elam MB; Cook GA; Park EA
Mol Cell Endocrinol; 2010 Feb; 315(1-2):159-67. PubMed ID: 19703515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
